机构:[1]Center of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China临床科室心脏内科中心首都医科大学附属安贞医院[2]Department of Thoracic Surgery, People Liberation Army General Hospital, Beijing, China
Urinary excretion of 8-iso-prostaglandin F-2 alpha (8-iso-PGF(2 alpha), a reliable biomarker for enhanced oxidant stress in vivo, has been described in association with diabetes and coronary heart disease. The aim of this study was to evaluate the relationship between urinary 8-iso-PGF(2 alpha) levels and the characteristics of coronary culprit lesion in diabetic patients with acute coronary syndrome (ACS). A total of 79 diabetic patients with ACS were included. iMAP intravascular ultrasound (iMAP-IVUS) was performed to evaluate the characteristics of culprit plaques. Fasting urinary 8-iso-PGF(2 alpha) level was measured and corrected by creatinine clearance. iMAP-NUS data showed culprit plaques in high urinary 8-iso-PGF(2 alpha) level patients had a greater percentage of necrotic core and less fibrous components. High urinary 8-iso-PGF(2 alpha) levels were correlated with increased necrotic plaque components (r = 0.325, P = 0.003). Meanwhile, the presence of thin-capped fibroatheroma (50.0% versus 11.5%, P = 0.003), ruptured plaques (30.8% versus 7.7%, P = 0.035), and thrombus (38.5% versus 7.7%, P = 0.008) were significantly more frequent in the upper tertile of urinary 8-iso-PGF(2 alpha) levels than in the low tertile. Multivariate analysis showed high levels of urinary 8-iso-PGF(2 alpha). (OR 4.240, P = 0.007) was independently associated with the presence of vulnerable culprit plaque in diabetic ACS patients. Urinary 8-iso-PGF(2 alpha) also displayed a significant value in predicting vulnerable plaques in diabetic patients with ACS by constructing the receiver-operating characteristic (ROC) curve (Area under the ROC curve: 0.713, P = 0.001). Urinary 8-iso-PGF(2 alpha) levels are associated with the vulnerability of the coronary culprit lesion in diabetic patients with ACS and may provide additional information for risk assessment in suspected vulnerable patients.
基金:
Beijing Health Special Foundation [JING 15-10]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|4 区医学
小类|4 区心脏和心血管系统
最新[2023]版:
大类|4 区医学
小类|4 区心脏和心血管系统
JCR分区:
出版当年[2017]版:
Q3CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q3CARDIAC & CARDIOVASCULAR SYSTEMSQ4CARDIAC & CARDIOVASCULAR SYSTEMS
第一作者机构:[1]Center of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China[*1]Center of Cardiology, Beijing An Zhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang district, Beijing 100029, China.
通讯作者:
通讯机构:[1]Center of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China[*1]Center of Cardiology, Beijing An Zhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang district, Beijing 100029, China.
推荐引用方式(GB/T 7714):
Gong Su ,Tao Zhang ,Hong-Xia Yang ,et al.Association of Isoprostanes-Related Oxidative Stress with Vulnerability of Culprit Lesions in Diabetic Patients with Acute Coronary Syndrome[J].INTERNATIONAL HEART JOURNAL.2019,60(2):271-279.doi:10.1536/ihj.18-233.
APA:
Gong Su,,Tao Zhang,,Hong-Xia Yang,,Wen-Long Dai,,Tao Wang,...&Shu-Hua Mi,.(2019).Association of Isoprostanes-Related Oxidative Stress with Vulnerability of Culprit Lesions in Diabetic Patients with Acute Coronary Syndrome.INTERNATIONAL HEART JOURNAL,60,(2)
MLA:
Gong Su,,et al."Association of Isoprostanes-Related Oxidative Stress with Vulnerability of Culprit Lesions in Diabetic Patients with Acute Coronary Syndrome".INTERNATIONAL HEART JOURNAL 60..2(2019):271-279